CCL3 and metabolic dysfunction-associated steatotic liver disease: In NAFLD, CCL3 may also be involved in the infiltration of inflammatory cells in the liver, promoting liver inflammation and fibrosis [21], which may in turn promote the development of atherosclerosis.